Month: June 2020

ORION CORPORATION STOCK EXCHANGE RELEASE 25 JUNE 2020 at 8.30 EEST                      The cancellation of Orion Corporation shares entered in the Trade RegisterThe cancellation of 63,650 Orion Corporation A shares and 59,900 B shares has today on 25 June 2020 been entered in the Trade Register. The cancellation reduces the number of Orion A and B shares with the corresponding amounts but has no effect on the share capital. The Board of Directors of Orion Corporation decided on the share cancellation on 15 June 2020.The total number of shares in Orion Corporation after the share cancellation is 141 134 278, of which 35,443,475 are A shares and 105,690,803 are B shares. The total number of votes of the company’s shares is 814,560,303 and Orion holds 671,082 B shares as treasury shares.ORION CORPORATION                                                                ...

ORION OYJ                          PÖRSSITIEDOTE                  25.6.2020        KLO 8.30         Orion Oyj:n osakkeiden mitätöinti merkitty kaupparekisteriinOrion Oyj:n 63 650 A-osakkeen ja 59 900 B-osakkeen mitätöinti on tänään 25.6.2020 merkitty kaupparekisteriin. Mitätöinti pienentää Orionin A- ja B-osakkeiden lukumääriä vastaavilla määrillä, mutta ei vaikuta yhtiön osakepääomaan. Orion Oyj:n hallitus päätti osakkeiden mitätöinnistä 15.6.2020.Osakkeiden mitätöinnin jälkeen Orion Oyj:n osakkeiden kokonaismäärä on 141 134 278, joista A-osakkeita on 35 443 475 ja B-osakkeita 105 690 803. Yhtiön osakkeiden tuottama äänimäärä on yhteensä 814 560 303, ja Orionin hallussa on yhteensä 671 082 yhtiön omaa B-osaketta.ORION OYJ                                                                                                                                 ...

WISeKey to Ring the Nasdaq Stock Market Closing Bell on June 30Geneva – June 25, 2020 – WISeKey International Holding Ltd (“WISeKey”, SIX: WIHN / Nasdaq: WKEY), a leading cybersecurity and IoT company, today announced that its Chief Executive Officer, Carlos Moreira will virtually ring the Nasdaq closing bell on Tuesday, June 30, 2020.  To celebrate this occasion, Mr. Moreira will be joined by other members of the management team and employees from around the globe.

Amsterdam, The Netherlands, June 25, 2020 – Kiadis Pharma N.V. (“Kiadis” or the “Company”) (Euronext Amsterdam and Brussels: KDS), a clinical stage biopharmaceutical company, and The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital (OSUCCC-James), today announced that the first patient has been enrolled and treated in a phase I, first-in-human clinical trial in patients with relapsed/refractory acute myeloid leukemia (“R/R AML”) with off-the-shelf Natural Killer (“NK”) cells manufactured at the Cell Therapy laboratory at the OSUCCC-James using Kiadis’ FC21 and proprietary universal donor platforms. The trial is being conducted at the OSUCCC-James and is expected to provide valuable data to support Kiadis’ K-NK003 development program.The phase I study, NCT04220684, will evaluate the NK cell product in...

Press ReleaseNokia launches cloud-native Digital Operations Center software to drive 5G monetization  Digital Operations Center is Nokia’s first automated, cross-domain, digital service and network slice management software productDigital Operations Center enables a new slice-based innovation ecosystem and new revenue opportunities by offering Network as a Service capabilities to new industries, or verticalsDigital Operations Center is cloud-native, and built on Nokia’s Common Software Foundation to give scale, flexibility, and operational efficiencies25 June 2020 Espoo, Finland – Nokia today introduced its cloud-native Digital Operations Center software solution to give communication service providers (CSPs) new revenue-enhancing opportunities with an automated platform that manages 5G slice-based services securely and cost effectively...

Issy-les-Moulineaux, June 25, 2020 – Sodexo (NYSE Euronext Paris FR 0000121220-OTC: SDXAY).  Following recent discussions with USPP debt holders, Sodexo has decided to exercise its right to reimburse its USD 1.6bn outstanding debt to ensure independence of action. The different USPP notes had been put in place between 2011 and 2018 to finance acquisitions in the US.With liquidity1 of nearly 5 billion euro at the end of May, including the recent 1.5 billion euro bond issue in April, the Group has the resources to finance the reimbursement and maintain a strong financial structure.The Group intends to proceed with this reimbursement before year end closing. As per the conditions of the USPP debt agreements, the reimbursement includes a make-whole2 of approximately €149m. By anticipating the reimbursement of this debt, future financial...

Issy-les-Moulineaux, le 25 juin 2020 – Sodexo (NYSE Euronext Paris FR 0000121220-OTC : SDXAY). Suite à des discussions récentes avec les détenteurs de ses emprunts USPP, Sodexo a décidé d’exercer son droit au remboursement de son encours de 1,6 milliard US$ pour préserver sa liberté d’action. Les emprunts USPP avaient été mis en place entre 2011 et 2018 pour financer des acquisitions aux Etats-Unis.Avec des liquidités1 disponibles de près de 5 milliards d’euros à fin mai, dont 1,5 milliard d’euros levé sur le marché obligataire en avril dernier, le Groupe dispose des ressources nécessaires pour financer ce remboursement tout en maintenant une structure financière solide.Le Groupe entend procéder à ce remboursement d’ici la clôture de l’exercice. Conformément aux conditions des emprunts USPP, ce remboursement inclut une indemnité2...

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA OR JAPANBasel, Switzerland, June 25, 2020Basilea Pharmaceutica Ltd. (SIX: BSLN, the “Offeror”) announces the publication of a partial repurchase offer of at least CHF 90 million and up to CHF 110 million in principal amount of its outstanding convertible bonds due 2022 (the “Repurchase Offer”). The Repurchase Offer price amounts to 100.50% of par plus accrued and unpaid interest. The cooling-off period during which no tenders are accepted commences on 26 June 2020 and ends on 9 July 2020. The tender offer period is expected to commence on 10 July 2020 and to expire on 16 July 2020 at 4pm CEST. The settlement date is expected to occur on July 28, 2020. The bonds are listed and traded at SIX Swiss Exchange (ISIN:...

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA OR JAPANBasel, Schweiz, 25. Juni 2020Basilea Pharmaceutica AG (SIX: BSLN, die „Anbieterin“) gibt die Veröffentlichung eines teilweisen Rückkaufangebots über mindestens CHF 90 Millionen und bis zu CHF 110 Millionen Nennwert ihrer ausstehenden Wandelanleihe mit Fälligkeit 2022 (das „Rückkaufsangebot“) bekannt. Der Preis des Rückkaufangebots beläuft sich auf 100.50 % des Nennwerts zuzüglich aufgelaufener und nicht bezahlter Zinsen. Die Stillhalteperiode, während der keine Angebote angenommen werden, beginnt am 26. Juni 2020 und endet am 9. Juli 2020. Die Rückkaufangebotsfrist beginnt voraussichtlich am 10. Juli 2020 und endet am 16. Juli 2020 um 16.00 Uhr MESZ. Der Zahlungstermin wird voraussichtlich auf den 28. Juli 2020 fallen....

TORONTO, June 25, 2020 (GLOBE NEWSWIRE) — African Gold Group, Inc. (TSX-V: AGG) (“AGG” or the “Company”) would like to invite interested shareholders and the general public to join Danny Callow, Chief Executive Officer, Andy Rompel, VP Exploration, Scott Eldridge, Non-Executive Chairman and Jan-Erik Back, Vice Chairman, for a live webinar discussing recently updated definitive feasibility study for its Kobada Gold Project.The investor webinar will take place on Thursday, June 25 at 10:00 am (EDT). Management will be available to answer written questions following the presentation. Online registration and participation details may be found at the following link:https://us02web.zoom.us/webinar/register/WN_vE_r8d_zSduQ4qaxb1aE_AAbout African Gold GroupAfrican Gold Group is a Canadian listed exploration and development company on the...